胃癌组织中上调的长链非编码RNA GMAN与患者转移相关,并通过竞争性结合GMAN-AS促进Ephrin A1翻译
研究从中国患者胃癌组织与非肿瘤组织中鉴定出151个显著上调的长链非编码RNA,其中GMAN在胃癌组织中升高,其上调与肿瘤转移及患者生存期缩短相关。GMAN通过竞争性结合反义RNA GMAN-AS促进ephrin A1信使RNA翻译,敲低或敲除GMAN或ephrin A1可降低胃癌细胞侵袭活性及小鼠体内转移形成能力。
要点
- 胃癌组织中GMAN表达升高,其上调与肿瘤转移和患者生存期缩短相关。
- GMAN通过竞争性结合GMAN-AS促进ephrin A1信使RNA翻译为蛋白。
- 敲低或敲除GMAN或ephrin A1可降低胃癌细胞侵袭活性及小鼠体内转移形成能力。
核心结论
- 研究鉴定出长链非编码RNA GMAN在患者胃癌组织中升高,与生存期和转移形成相关。
- GMAN通过竞争性结合GMAN-AS调控ephrin A1信使RNA的翻译。
- 敲低或敲除GMAN或ephrin A1可降低胃癌细胞系侵袭活性及注射小鼠后的转移形成能力。
- 作者认为这些基因可能被靶向用于预防或减少胃癌转移。
研究设计与样本
- 研究收集中国患者的胃肿瘤与非肿瘤组织,用微阵列分析长链非编码RNA水平、免疫组化分析蛋白、定量逆转录聚合酶链反应分析RNA,并与患者生存时间和肿瘤进展比较。
- 在BGC-823、SGC-7901和MKN45细胞系中使用小干扰RNA、短发夹RNA或CRISPR/Cas9载体敲低或敲除RNA水平,在HGC-27细胞中通过转染质粒过表达基因。
- 细胞通过Northern印迹、免疫印迹、多聚核糖体谱分析和细胞侵袭实验分析。
- 细胞注射入裸鼠或SCID小鼠尾静脉或脾脏,收集肺和肝组织并计数转移灶。
- 长链非编码RNA通过互补DNA末端快速扩增克隆,其与其他基因的相互作用通过RNA拉下和映射实验确定。
主要发现
- 微阵列分析鉴定出151个长链非编码RNA在胃肿瘤组织中的表达水平显著高于非肿瘤组织。
- GMAN在胃肿瘤组织中的水平高于非肿瘤组织,其上调与肿瘤转移及患者生存期缩短相关。
- 在BGC-823和MKN45细胞中敲低GMAN不影响增殖、集落形成或黏附,但降低Transwell实验中的侵袭活性。
- 在HGC-27细胞中异位表达GMAN增加侵袭活性。
- 敲低GMAN的BGC-823和MKN45细胞注射入裸鼠尾静脉后形成的转移灶减少。
临床怎么用
- 作者认为这些基因可能被靶向用于预防或减少胃癌转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We aimed to identify long noncoding RNAs (lncRNAs) that are up-regulated in gastric cancer tissues from patients and study their function in gastric tumor metastasis. METHODS: We collected gastric tumor and nontumor tissues from patients in China and analyzed levels of lncRNAs by microarray analysis, proteins by immunohistochemistry, and RNAs by quantitative reverse-transcription polymerase chain reaction; we compared these with survival times of patients and tumor progression. RNA levels were knocked down or knocked out in BGC-823, SGC-7901, and MKN45 cell lines using small interfering or short hairpin RNAs or clustered regularly interspaced short palindromic repeats (ie, CRISPR)/CRISPR associated protein 9 (ie, Cas9) vectors. Genes were overexpressed from transfected plasmids in HGC-27 cells. Cells were analyzed by Northern blot and immunoblot, polysome profiling assay, and cell invasion assay. Cells were injected into the tail veins or spleens of nude mice or SCID mice; lung and liver tissues were collected, and metastases were counted. lncRNAs were cloned by using rapid amplification of complementary DNA ends. Their interactions with other genes were determined by RNA pulldown and mapping assays. RESULTS: In microarray analyses, we identified 151 lncRNAs expressed at significantly higher levels in gastric tumor vs nontumor tissues. Levels of an lncRNA that we called gastric cancer metastasis associated long noncoding RNA (GMAN) were increased in gastric tumor tissues, compared with nontumor tissues; its up-regulation was associated with tumor metastasis and shorter survival times of patients. The GMAN gene overlaps with the ephrin A1 gene (EFNA1) and was highly expressed in BGC-823 and MKN45 cells. Knockdown of GMAN in these cells did not affect proliferation, colony formation, or adhesion but did reduce their invasive activity in Transwell assays. Ectopic expression of GMAN increased the invasive activity of HGC-27 cells. BGC-823 and MKN45 cells with knockdown of GMAN formed fewer metastases after injection into tail veins of nude mice. Knockdown or knockout of GMAN also reduced levels of ephrin A1 protein in cells. We found that GMAN promoted translation of ephrin A1 messenger RNA into protein by binding to the antisense GMAN RNA (GMAN-AS)-this antisense sequence is also complementary to that of ephrin A1 mRNA. Levels of ephrin A1 protein were also increased in gastric tumors from patients with metastases than in those without metastases. Knockout of ephrin A1 in BGC-823 cells reduced their invasive activity in Transwell assays and ability to form metastases after injection into SCID mice. Ectopic expression of ephrin A1 in BGC-823 cells with knockdown or knockout of GMAN restored their invasive activities and ability form metastases in nude or SCID mice. A CRISPR/Cas9-based strategy to disrupt the GMAN gene significantly reduced the numbers of metastases formed from SGC-7901 cells in mice. CONCLUSIONS: We identified an lncRNA, which we call GMAN, that is increased in gastric tumors from patients and associated with survival and formation of metastases. It regulates translation of ephrin A1 mRNA by binding competitively to GMAN-AS. Knockdown or knockout of GMAN or ephrin A1 in gastric cancer cell lines reduces their invasive activity and ability to form metastases after injection into mice. These genes might be targeted to prevent or reduce gastric cancer metastasis.
引用
- Zhuo W, Liu Y, Li S, et al. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. Gastroenterology. 2018. PMID: 30445010. doi:10.1053/j.gastro.2018.10.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。